Nestlé Sells Galderma

[Guide]

Bloomberg reports, "Nestle said Thursday it would consider new owners for its dermatological business, a unit with $2.8 billion in annual revenue that Chief Executive Officer Mark Schneider said may no longer fit with the company’s overall strategy of focusing on products such as coffee, water and pet food." [1]

Nestle owns Galderma, which is part of its 'dermatological business' or 'Nestlé Skin Health.' As David Pascoe puts it, "Lets hope that a pharma with deep pockets emerges, one that sees value in the assets of Galderma and further sees a future in developing new treatments that help rosacea sufferers." [2]

Rosacea sufferers usually are very much aware of Galderma's Soolantra, Oracea, Mirvaso and Metrogel (Metrocream). We shall wait and see what happens. 

End Notes

[1] Nestle's Step Away From Skin Health Reignites L'Oreal Sale Talk
By Thomas Mulier  and Corinne Gretler, Bloomberg

[2] Galderma for sale – why we need the right buyer, by David Pascoe, Rosacea Support Group

[Guide]

It was announced by Galderma on its website on May 16, 2019, "Nestlé today announced that it has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion. The proposed transaction will be subject to employee consultations and approval of regulatory authorities and is expected to close in the second half of 2019."

 

[Guide]

October 2, 2019

Galderma to become the world’s largest independent global dermatology company after completion of CHF 10.2 billion carve-out of Nestlé Skin Health